An overview of using fungal DNA for the diagnosis of invasive mycoses

References

• White PL, Alanio A, Criciani M, et al. Nucleic acid tools for invasive fungal disease diagnosis. Curr Fungal Infection Rep. 2020;14.DOI:76–88.
   Web of Science ®Google Scholar
• Baddley JW, Thompson GR, Chen SCAS, et al. COVID-19 associated Invasive Fungal Infection. In press. 2021; Open Forum Infect Dis. 8. DOI:https://doi.org/10.1093/ofid/ofab510
   Google Scholar
• Schauwvlieghe A, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–792. DOI:https://doi.org/10.1016/S2213-2600(18)30274-1.
   PubMed Web of Science ®Google Scholar
• www.fpcri.eu. Last accessed December 2021.
   Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–1376. DOI:https://doi.org/10.1093/cid/ciz1008Latest.
   PubMed Web of Science ®Google Scholar
• www.QCMD.org. Accessed December 2021.
   Google Scholar
• Lyon GM, Abdul-Ali D, Loeffler J, et al. Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis. J Clin Microbiol. 2013;51(7):2403–2405. DOI:https://doi.org/10.1128/JCM.00744-13.
   PubMed Web of Science ®Google Scholar
• Barnes RA, White PL, Morton CO, et al. Diagnosis of aspergillosis by PCR: clinical considerations and technical tips. Med Mycol. 2018 Apr 1;56(suppl_1):60–72.
   PubMedGoogle Scholar
• Alanio A, Hauser PM, Lagrou K, et al. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2386–2396.
   PubMed Web of Science ®Google Scholar
• Barnes RA, Stocking K, Bowden S, et al. Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway. J Infect. 2013;67(3):206–214.
   PubMed Web of Science ®Google Scholar
• Aguado JM, Vázquez L, Fernández-Ruiz M, et al., Spanish Stem Cell Transplantation Group, Study Group of Medical Mycology of the Spanish Society of Clinical Microbiology and Infectious Diseases, Spanish Network for Research in Infectious Diseases. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. Clin Infect Dis. 2015;60(3):405–414. DOI:https://doi.org/10.1093/cid/ciu833.
   PubMed Web of Science ®Google Scholar
• Morrissey CO, Chen SC, Sorrell TC, et al. Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis. 2013; 13(6):519–528. Epub 2013 Apr 30. PMID: 23639612. DOI:https://doi.org/10.1016/S1473-3099(13)70076-8.
   PubMed Web of Science ®Google Scholar
• Arvanitis M, Anagnostou T, Mylonakis E. Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis. Clin Infect Dis. 2015;61(8):1263–1272.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis. 2012 May;54(9):1240–1248.
   PubMed Web of Science ®Google Scholar
• Spreadbury C, Holden D, Aufauvre-Brown A, et al. Detection of Aspergillus fumigatus by polymerase chain reaction. J Clin Microbiol. 1993 Mar;31(3):615–621. DOI:https://doi.org/10.1128/jcm.31.3.615-621.1993.
   PubMed Web of Science ®Google Scholar
• White PL, Bretagne S, Klingspor L, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol. 2010 Apr;48(4):1231–1240. DOI:https://doi.org/10.1128/JCM.01767-09.
   PubMed Web of Science ®Google Scholar
• White PL, Perry MD, Loeffler J, et al. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol. 2010 Oct;48(10):3753–3755. DOI:https://doi.org/10.1128/JCM.01466-10.
   PubMed Web of Science ®Google Scholar
• Loeffler J, Mengoli C, Springer J, et al. Analytical Comparison Of In Vitro-Spiked Human Serum And Plasma for PCR-Based Detection of Aspergillus fumigatus DNA: a Study by the European Aspergillus PCR Initiative. J Clin Microbiol. 2015 Sep;53(9):2838–2845. DOI:https://doi.org/10.1128/JCM.00906-15.
   PubMed Web of Science ®Google Scholar
• White PL, Barnes RA, Springer J, et al. Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative. J Clin Microbiol. 2015 Sep;53(9):2832–2837. DOI:https://doi.org/10.1128/JCM.00905-15.
   PubMed Web of Science ®Google Scholar
• Springer J, White PL, Hamilton S, et al. Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations. J Clin Microbiol. 2016 Mar;54(3):705–711. DOI:https://doi.org/10.1128/JCM.02814-15.
   PubMed Web of Science ®Google Scholar
• Rogers TR, Morton CO, Springer J, et al. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies. Br J Haematol. 2013 May;161(4):517–524. DOI:https://doi.org/10.1111/bjh.12285.
   PubMed Web of Science ®Google Scholar
• White PL, Bretagne S, Caliendo AM, et al. Aspergillus Polymerase Chain Reaction-An Update on Technical Recommendations, Clinical Applications, and Justification for Inclusion in the Second Revision of the EORTC/MSGERC Definitions of Invasive Fungal Disease. Clin Infect Dis. 2021 Mar 12;72(Suppl 2):S95–S101.
   PubMedGoogle Scholar
• Cornelius JC, Hong Nguyen M. Finding the “Missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013. May; 56(9):1284–1292
   PubMed Web of Science ®Google Scholar
• Rocchi S, Scherer E, Mengoli C, et al. Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: a study by the fungal PCR Initiative and the Modimucor study group. Med Mycol. 2021 Feb 4;59(2):126–138.
   PubMed Web of Science ®Google Scholar
• Millon L, Larosa F, Lepiller Q, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013 May;56(10):e95–101. DOI:https://doi.org/10.1093/cid/cit094.
   PubMed Web of Science ®Google Scholar
• Millon L, Herbrecht R, Grenouillet F, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2016 Sep;22(9):810 e1–810 e8. DOI:https://doi.org/10.1016/j.cmi.2015.12.006.
   Web of Science ®Google Scholar
• Springer J, Lackner M, Ensinger C, et al. Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples. J Med Microbiol. 2016 Dec;65(12):1414–1421. DOI:https://doi.org/10.1099/jmm.0.000375.
   PubMedGoogle Scholar
• Bergeron A, Porcher R, Sulahian A, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012;119(8):1831–1837. quiz Feb 23. DOI:https://doi.org/10.1182/blood-2011-04-351601
   PubMed Web of Science ®Google Scholar
• Egger M, Jenks JD, Hoenigl M, et al. Blood Aspergillus PCR: the Good, the Bad, and the Ugly. J Fungi (Basel). 2020 Jan 27;6(1). DOI:https://doi.org/10.3390/jof6010018.
   Google Scholar
• Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis. 2009 Dec 1;49(11):1688–1693.
   PubMed Web of Science ®Google Scholar
• de Heer K, Gerritsen MG, Visser CE, et al. Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2019May20; CD012399 5. DOI:https://doi.org/10.1002/14651858.CD012399.pub2.
   Google Scholar
• Alanio A, Gits-Muselli M, Lanternier F, et al., French Mycoses Study Group. Evaluation of a New Histoplasma spp. Quantitative RT-PCR Assay. J Mol Diagn. 2021 Jun; 23(6):698–709.
   PubMed Web of Science ®Google Scholar
• Cruciani M, Mengoli C, Barnes R, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev. 2019Sep3; CD009551 9. DOI:https://doi.org/10.1002/14651858.CD009551.pub4.
   Google Scholar
• Imbert S, Meyer I, Palous M, et al. Aspergillus PCR in bronchoalveolar lavage fluid for the diagnosis and prognosis of aspergillosis in patients with hematological and non-hematological conditions. Front Microbiol. 2018;9:1877.
   PubMed Web of Science ®Google Scholar
• Scherer E, Iriart X, Bellanger AP, et al. Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary Mucormycosis. J Clin Microbiol. 2018 Aug;56(8). doi:https://doi.org/10.1128/JCM.00289-18.
   PubMed Web of Science ®Google Scholar
• Robert-Gangneux F, Belaz S, Revest M, et al. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study. J Clin Microbiol. 2014 Sep;52(9):3370–3376. DOI:https://doi.org/10.1128/JCM.01480-14.
   PubMed Web of Science ®Google Scholar
• Doyle L, Vogel S, Procop GW. Pneumocystis PCR: it Is Time to Make PCR the Test of Choice. Open Forum Infect Dis. 2017;4(4):ofx193. Fall. DOI:https://doi.org/10.1093/ofid/ofx193.
   PubMed Web of Science ®Google Scholar
• Springer J, Schlossnagel H, Heinz W, et al. A novel extraction method combining plasma with a whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis. J Clin Microbiol. 2012 Aug;50(8):2585–2591. DOI:https://doi.org/10.1128/JCM.00523-12.
   PubMed Web of Science ®Google Scholar
• Springer J, White PL, Kessel J, et al. A comparison of aspergillus and mucorales PCR testing of different bronchoalveolar lavage fluid fractions from patients with suspected invasive pulmonary fungal disease. J Clin Microbiol. 2018 Feb;56(2). doi:https://doi.org/10.1128/JCM.01655-17.
   Web of Science ®Google Scholar
• Rath PM, Steinmann J. Overview of commercially available PCR assays for the detection of aspergillus spp. DNA in patient samples. Front Microbiol. 2018;9:740.
   PubMed Web of Science ®Google Scholar
• Morton CO, White PL, Barnes RA, et al. Determining the analytical specificity of PCR-based assays for the diagnosis of IA: what is Aspergillus? Med Mycol. 2017;55(4):402–413. DOI:https://doi.org/10.1093/mmy/myw093.
   PubMed Web of Science ®Google Scholar
• White PL, Mengoli C, Bretagne S, et al. European Aspergillus PCR Initiative (EAPCRI). Evaluation of Aspergillus PCR protocols for testing serum specimens. J Clin Microbiol. 2011;49(11):3842–3848.
   PubMed Web of Science ®Google Scholar
• Arvanitis M, Ziakas PD, Zacharioudakis IM, et al. PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol. 2014;52:3731–3742.
   PubMed Web of Science ®Google Scholar
• Mengoli C, Cruciani M, Barnes RA, et al. Performance of Polymerase Chain Reaction for diagnosing invasive aspergillosis: systematic Review and Meta-analysis. Lancet Infect Dis. 2009;9:89–96.
   PubMed Web of Science ®Google Scholar
• Cruciani M, White PL, Mengoli C, et al. Fungal PCR Initiative. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. J Antimicrob Chemother. 2021Feb11;76(3):635–638. PMID: 33374010. DOI:https://doi.org/10.1093/jac/dkaa498
   PubMed Web of Science ®Google Scholar
• Avni T, Levy I, Sprecher H, et al. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. J Clin Microbiol. 2012;50:3652–3658.
   PubMed Web of Science ®Google Scholar
• Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol. 2007;24(2):89–94.
   PubMedGoogle Scholar
• Sun W, Wang K, Gao W, et al. Evaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate meta-analysis and systematic review. PLoS One. 2011;6(12):e28467.
   PubMed Web of Science ®Google Scholar
• Heng SC, Morrissey O, Chen SC, et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis. Crit Rev Microbiol. 2015;41(1):124–134.
   PubMed Web of Science ®Google Scholar
• Loeffler J, Hafner J, Mengoli C, et al. Prospective biomarker screening for diagnosis of invasive Aspergillosis in high-risk pediatric patients. J Clin Microbiol. 2016 Dec 28;55(1):101–109.
   PubMed Web of Science ®Google Scholar
• White PL, Dhillon R, Cordey A, et al. A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. Clin Infect Dis. 2020Aug; 29: ciaa1298. Epub ahead of print. DOI:https://doi.org/10.1093/cid/ciaa1298.
   Google Scholar
• Koehler P, Bassetti M, Chakrabarti A, et al. European Confederation of Medical Mycology; International Society for Human Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021 Jun;21(6):e149–e162.International.
   PubMed Web of Science ®Google Scholar
• Salmanton-García J, Sprute R, Stemler J, et al. FungiScope European Confederation of Medical Mycology/The International Society for Human and Animal Mycology Working Group. COVID-19-Associated Pulmonary Aspergillosis. 2020. Emerg Infect Dis. 2021 March-August;27(4):1077–1086. DOI:https://doi.org/10.3201/eid2704.204895.
   PubMedGoogle Scholar
• Armstrong-James D, Youngs J, Bicanic T, et al Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J. 2020 Oct 1;56(4):2002554.
   PubMed Web of Science ®Google Scholar
• Chong GM, van der Beek MT, von Dem Borne PA, et al. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis. J Antimicrob Chemother. 2016 Dec;71(12):3528–3535.
   PubMed Web of Science ®Google Scholar
• Novak-Frazer L, Anees-Hill SP, and Hassan D, et al. Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens. J Antimicrob Chemother. 2020Dec1;75(12):3501–3509. . DOI:https://doi.org/10.1093/jac/dkaa357
   PubMed Web of Science ®Google Scholar
• Matteo B, Elie A, Bart-Jan K, et al. EORTC/MSGERC Definitions of Invasive Fungal Diseases: summary of Activities of the Intensive Care Unit Working Group. Clin Infect Dis. 2021 Mar 12;72(Suppl 2):S121–S127.
   PubMedGoogle Scholar
• Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45:789–805.
   PubMed Web of Science ®Google Scholar
• Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011;49(2):665–670.
   PubMed Web of Science ®Google Scholar
• Fuchs S, Lass-Flörl Candand PW. Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients. J Fungi (Basel). 2019 Sep 17;5(3):86.
   Google Scholar
• Cornelius J, Peter G, Jose V, et al. Angela M. Caliendo. Detecting infections rapidly and easily for Candidemia Trial, part 2 (DIRECT2): aProspective, multicenter study of the T2Candida Panel. Clin Infect Dis. 2018May17;66(11):1678–1686. . DOI:https://doi.org/10.1093/cid/cix1095
   PubMed Web of Science ®Google Scholar
• MaikenCavling A, Jakob SA, A Madskristian H, et al. Diagnostic performance of T2Candida among ICU patients with risk factors for invasive Candidiasis. Open Forum Infect Dis. 2019 May;6(5). DOI:https://doi.org/10.1093/ofid/ofz136.
   Google Scholar
• Emilio C-B, Iker F-R, María L-G, et al. Candidemia Diagnosis With T2 Nuclear Magnetic Resonance in a PICU: a new approach. Pediatr Crit Care Med. 2021 Feb 1;22(2):e109–e114.
   PubMed Web of Science ®Google Scholar
• Nieto M, Robles JC, Causse M, et al. Polymerase chain reaction versus blood culture to detect Candida species in high-risk patients with suspected invasive Candidiasis: the MICAFEM study. Infect Dis Ther. 2019;8(3):429–444.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Verweij PE, Arendrup MC, et al., ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect. 2012 Dec; 18(Suppl 7):9–18.
   PubMed Web of Science ®Google Scholar
• Sexton DJ, Kordalewska M, Bentz ML, et al. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay. J Clin Microbiol. 2018 Nov 27;56(12):e01337–18.
   PubMed Web of Science ®Google Scholar
• Leach L, Russell A, Zhu Y, et al. A Rapid and Automated Sample-to-Result Candida auris Real-Time PCR Assay for High-Throughput Testing of Surveillance Samples with the BD Max Open System. J Clin Microbiol. 2019 Sep 24;57(10):e00630–19.
   PubMed Web of Science ®Google Scholar
• Perlin DS, Wiederhold NP. Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification. J Infect Dis. 2017 Aug 15;216(suppl_3):S458–S46.
   PubMedGoogle Scholar
• Camp I, Spettel K, Willinger B. Molecular Methods for the Diagnosis of Invasive Candidiasis. J Fungi (Basel). 2020 Jul 6;6(3):101.
   Google Scholar
• White PL, Price JS, Cordey A, et al. Molecular Diagnosis of Yeast Infections. Current Fungal Infect Rep. 2021. In press 67–80. DOI:https://doi.org/10.1007/s12281-021-00421-x
   Google Scholar
• Gorton RL, Lewis White P, and Loeffler J, et al.,An evaluation of the analytical specificity of PCR assays for the detection of Candida species – a study by the ISHAM working group, the Fungal PCR initiative (FPCRI). Poster presentation at the 20th Congress of the International Society for Human and Animal Mycology 30/06/2018-04/07/2018 Amsterdam () 2018
   Google Scholar
• Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–899. DOI:https://doi.org/10.1093/cid/ciu959.
   PubMed Web of Science ®Google Scholar
• Lamoth F, Clancy CJ, Tissot F, et al. Philippe Eggimann, Ursula Flückiger, Martin Siegemund, Christina Orasch, Stefan Zimmerli,Thierry Calandra, Oscar Marchetti,Minh H Nguyen, and Pierre-Yves Bochud1, on behalf of the Fungal Infection Network of Switzerland (FUNGINOS). Performance of the T2Candida panel for the diagnosis of intra-abdominal candidiasis. Open Forum Infect Dis. 2020 Feb 27;7(3). DOI:https://doi.org/10.1093/ofid/ofaa075.
   Google Scholar
• Bomkamp JP, Sulaiman R, and Hartwell JL, et al. Evaluation of a rapid fungal detection panel for identification of candidemia at an academic medical center. J Clin Microbiol. 2020 24 Feb;58(3 140–1419 doi:https://doi.org/10.1128/JCM.01408-19.
   Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH. Diagnosing Invasive Candidiasis. J Clin Microbiol. 2018;56(5). DOI:https://doi.org/10.1128/JCM.01909-17
   Web of Science ®Google Scholar
• Falces-Romero I, Cendejas-Bueno E, Laplaza-Gonzalez M, et al. T2Candida((R)) to guide antifungal and length of treatment of candidemia in a pediatric multivisceral transplant recipient. Med Mycol Case Rep. 2018;21:66–68.
   PubMed Web of Science ®Google Scholar
• Christoph Z, Ines Zollner -S, Thomas V, et al. T2Candida magnetic resonance in patients with invasive candidiasis: strengths and limitations. Medical Mycology. 2020 July;58(5):632–638.
   PubMed Web of Science ®Google Scholar
• Munoz P, Vena A, Machado M, et al. T2CandidaMR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study. J Antimicrob Chemother. 2018;73(4):iv6–iv12. DOI:https://doi.org/10.1093/jac/dky047.
   PubMedGoogle Scholar
• White PL. Recent advances and novel approaches in laboratory based diagnostic mycology. Med Mycol. 2019;57(Supplement_3):S259–S66.
   PubMedGoogle Scholar
• Mylonakis E, Zacharioudakis IM, Clancy CJ, et al. Efficacy of T2 magnetic resonance assay in monitoring Candidemia after initiation of antifungal therapy: the serial therapeutic and antifungal monitoring protocol (STAMP) Trial. J Clin Microbiol. 2018;56(4). DOI:https://doi.org/10.1128/JCM.01756-17
   PubMed Web of Science ®Google Scholar
• Brunet K, Rammaert B. Mucormycosis treatment: recommendations, latest advances, and perspectives. J Mycol Med. 2020;30(3):101007.
   PubMed Web of Science ®Google Scholar
• Serris A, Danion F, Lanternier F. Disease entities in mucormycosis. J Fungi (Basel). 2019;5(1):23.
   PubMedGoogle Scholar
• Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34.
   PubMed Web of Science ®Google Scholar
• Koehler P, Mellinghoff SC, Stemler J, et al. Quantifying guideline adherence in mucormycosis management using the EQUAL score. Mycoses. 2020;63(4):343–351.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Mucormycosis ECMM MSG Global Guideline Writing Group. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019Dec;19(12):e405–e421. Epub 2019 Nov 5. PMID: 31699664. DOI:https://doi.org/10.1016/S1473-3099(19)30312-3
   PubMed Web of Science ®Google Scholar
• Millon L, Scherer E, Rocchi S, et al. Molecular strategies to diagnose mucormycosis. J Fungi (Basel). 2019;5:1.
   Google Scholar
• Dadwal SS, Kontoyiannis DP. Recent advances in the molecular diagnosis of mucormycosis. Expert Rev Mol Diagn. 2018;18(10):845–854.
   PubMed Web of Science ®Google Scholar
• Bretagne S. Primary diagnostic approaches of invasive aspergillosis--molecular testing. Med Mycol. 2011;49(Suppl1):S48–53.
   PubMedGoogle Scholar
• Hata DJ, Buckwalter SP, Pritt BS, et al. Real-time PCR method for detection of zygomycetes. J Clin Microbiol. 2008;46(7):2353–2358.
   PubMed Web of Science ®Google Scholar
• Bernal-Martinez L, Buitrago MJ, Castelli MV, et al. Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species. Clin Microbiol Infect. 2013;19(1):E1–7.
   PubMed Web of Science ®Google Scholar
• Springer J, Goldenberger D, Schmidt F, et al. Development and application of two independent real-time PCR assays to detect clinically relevant Mucorales species. J Med Microbiol. 2016;65(3):227–234.
   PubMedGoogle Scholar
• Hrncirova K, Lengerova M, Kocmanova I, et al. Rapid detection and identification of mucormycetes from culture and tissue samples by use of high-resolution melt analysis. J Clin Microbiol. 2010;48(9):3392–3394.
   PubMed Web of Science ®Google Scholar
• Caramalho R, Madl L, and Rosam K, et al. Evaluation of a novel mitochondrial pan-mucorales marker for the detection, identification, quantification, and growth stage determination of mucormycetes. J Fungi (basel). 2019;5(4):98. DOI:https://doi.org/10.3390/jof5040098 Retrieved 20 June 2021
   Google Scholar
• Bellanger AP, Berceanu A, Rocchi S, et al. Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis. Bone Marrow Transplant. 2018;53(9):1180–1183
   PubMed Web of Science ®Google Scholar
• Lengerova M, Racil Z, Hrncirova K, et al. Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis. J Clin Microbiol. 2014;52(8):2824–2828.
   PubMed Web of Science ®Google Scholar
• Kasai M, Harrington SM, Francesconi A, et al. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol. 2008;46(11):3690–3702.
   PubMed Web of Science ®Google Scholar
• Caillot D, Valot S, Lafon I, et al. Is It Time to Include CT ”Reverse Halo Sign” and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients? Open Forum Infect Dis. 2016;3(4):ofw190.
   PubMedGoogle Scholar
• Legrand M, Gits-Muselli M, Boutin L, et al. Detection of circulating mucorales DNA in critically ill burn patients: preliminary report of a screening strategy for early diagnosis and treatment. Clin Infect Dis. 2016;63(10):1312–1317.
   PubMed Web of Science ®Google Scholar
• Cushion MT. Are members of the fungal genus pneumocystis (a) commensals; (b) opportunists; (c) pathogens; or (d) all of the above? PLoS Pathog. 2010 6 (9) e1001009 Retrieved 20 June 2021 .
   PubMed Web of Science ®Google Scholar
• Salzer HJF, Schäfer G, Hoenigl M, et al. Clinical, diagnostic, and treatment disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia. Respiration. 2018;96:52–65.
   PubMed Web of Science ®Google Scholar
• White PL, Price JS, Backx M. Pneumocystis jirovecii pneumonia: epidemiology, Clinical Manifestation and Diagnosis. Curr Fungal Infection Rep. 2019;13:260–273.
   Web of Science ®Google Scholar
• Cordonnier C, Cesaro S, Maschmeyer G, et al. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2379–2385.
   PubMed Web of Science ®Google Scholar
• Beumer MC, Koch RM, van Beuningen D, et al. Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality. J Crit Care. 2019;50:59–65.
   PubMed Web of Science ®Google Scholar
• Alanio A, Dellière S, Voicu S, et al. The presence of Pneumocystis jirovecii in critically ill patients with COVID-19. J Infect. 2021;82:84–123.
   PubMed Web of Science ®Google Scholar
• Lagrou K, Chen S, Masur H, et al. Pneumocystis jirovecii Disease: basis for the revised EORTC/MSGERC Invasive fungal disease definitions in individuals without human immunodeficiency virus. Clin Infect Dis. 2021;72:S114–S120.
   PubMed Web of Science ®Google Scholar
• Lu Y, Ling G, Qiang C, et al. PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis. J Clin Microbiol. 2011;49:4361–4363.
   PubMed Web of Science ®Google Scholar
• Fan LC, Lu HW, and Cheng KB, et al. Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of pneumocystis jirovecii pneumonia: a Bivariate Meta-Analysis and Systematic Review. PLoS One. 2013 8 (9) e73099 Retrieved 20 June 2021 .
   PubMed Web of Science ®Google Scholar
• Szvalb AD, Malek AE, Jiang Y, et al. Serum (1,3)-Beta-D-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. J Infect. 2020;81:443–451.
   PubMed Web of Science ®Google Scholar
• Mercier T, Aissaoui N, Gits-Muselli M, et al. Variable correlation between bronchoalveolar lavage fluid fungal load and serum-(1,3)-β-d-glucan in patients with pneumocystosis—a multicenter ecmm excellence center study. J Fungi. 2020;6:327.
   Web of Science ®Google Scholar
• Robin C, Alanio A, Gits-Muselli M, et al. Molecular demonstration of a pneumocystis outbreak in stem cell transplant patients: evidence for transmission in the daycare center. Front Microbiol. 2017;8. DOI:https://doi.org/10.3389/fmicb.2017.00700.
   Google Scholar
• Louis M, Guitard J, Jodar M, et al. Impact of HIV infection status on interpretation of quantitative PCR for detection of pneumocystis jirovecii. J Clin Microbiol. 2015;53:3870–3875.
   PubMed Web of Science ®Google Scholar
• Gits-Muselli M, White PL, Mengoli C, et al. The Fungal PCR Initiative’s evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: toward a standard for a diagnostics assay. Med Mycol. 2020;58:779–788.
   PubMed Web of Science ®Google Scholar
• Dellière S, Gits-Muselli M, and White PL, et al. Quantification of pneumocystis jirovecii: cross-platform comparison of one QPCR assay with leading platforms and six master mixes. J Fungi. 2020 6 (1) 9 doi:https://doi.org/10.3390/jof6010009 Retrieved 20 June 2021 .
   Web of Science ®Google Scholar
• Azoulay E, Roux A, Vincent F, et al. A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure. Am J Respir Crit Care Med. 2018;198:1519–1526.
   PubMed Web of Science ®Google Scholar
• Delliere S, Hamane S, Aissaoui N, et al. Increased sensitivity of a new commercial reverse transcriptase-quantitative PCR for the detection of Pneumocystis jirovecii in respiratory specimens. Med Mycol. 2021;59:845–848. In press. DOI:https://doi.org/10.1093/mmy/myab029.
   PubMed Web of Science ®Google Scholar
• White PL, Price JS, Backx M. Therapy and Management of Pneumocystis jiroveciiInfection. J Fungi (Basel). 2018 Nov 22;4(4):127.
   Google Scholar
• Jordanides NE, Allan EK, McLintock LA, et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transplantation. 2005 Feb;35(4):389–395.
   PubMed Web of Science ®Google Scholar
• Bezdicek M, Lengerova M, Ricna D, et al. Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis. Med Mycol. 2016 Oct 1;54(7):714–724.
   PubMed Web of Science ®Google Scholar
• Valero C, de la Cruz-villar L, Ó Z, et al. New Panfungal Real-Time PCR Assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2016 Dec;54(12):2910–2918.
   PubMed Web of Science ®Google Scholar
• Senchyna F, Hogan CA, Murugesan K, et al. Clinical accuracy and impact of plasma cell-Free DNA Fungal PCR panel for non-invasive diagnosis of fungal infection. Clin Infect Dis. 2021Feb19;73:1677–1684. ciab158. DOI:https://doi.org/10.1093/cid/ciab158
   PubMed Web of Science ®Google Scholar
• Khot PD, Ko DL, Fredricks DN. Sequencing and analysis of fungal rRNA operons for development of broad-range fungal PCR assays. Appl Environ Microbiol. 2009;75(6):1559–1565.
   PubMed Web of Science ®Google Scholar
• Hien JY, Liu CJ, Chuang PC, et al. Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii. Future Microbiol. 2017 Jan;12:29–37.
   PubMed Web of Science ®Google Scholar
• Poh TY, Nabm A, Chan LLY, et al. Evaluation of droplet digital polymerase chain reaction (ddPCR) for the absolute quantification of Aspergillus species in the Human Airway. Int J Mol Sci. 2020 Apr 26;21(9):3043.
   Web of Science ®Google Scholar
• White PL, Parr C, Barnes RA. Predicting invasive Aspergillosis in hematology patients by combining clinical and genetic risk factors with early diagnostic biomarkers. J Clin Microbiol. 2017 Dec 26;56(1):1122–1700.
   Web of Science ®Google Scholar
• Fisher CE, Hohl TM, Fan W, et al. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation. Blood. 2017 May 11;129(19):2693–2701.
   PubMed Web of Science ®Google Scholar
• Rhodes J, Abdolrasouli A, Dunne K, et al., Tracing patterns of evolution and acquisition of drug resistant Aspergillus fumigatus infection from the environment using population genomics, Nature Microbiol, In press; pre-print: bioRxiv 2021.04.07.438821
   Google Scholar
• Abdolrasouli A, Rhodes J, Beale MA, et al. Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing. MBio. 2015 Jun 2;6(3):e00536.
   PubMed Web of Science ®Google Scholar
• Garnaud C, Botterel F, Sertour N, et al. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles. J Antimicrob Chemother. 2015;70(9):2556–2565.
   PubMed Web of Science ®Google Scholar
• Bruno VM, Shetty AC, Yano J, et al. Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome. MBio. 2015;6:e00182–15.
   PubMed Web of Science ®Google Scholar
• Nilsson RH, Anslan S, Bahram M, et al. Mycobiome diversity: high-throughput sequencing and identification of fungi. Nat Rev. 2019;17:95–109.
   Google Scholar
• Opathy C. Gabaldón T Recent trends in molecular diagnostics of yeast infections: from PCR to NGS. FEMS Microbiol Rev. 2019 Sep 1;43(5):517–547.
   PubMed Web of Science ®Google Scholar
• Cruciani M, Mengoli C, Loeffler J, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev. 2015 Oct 1; 10: CD009551. PMID: 26424726. doi: https://doi.org/10.1002/14651858.CD009551.pub3.
   Google Scholar
• http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018087812. Accessed October 2021.
   Google Scholar
• http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018088037. Accessed October 2021.
   Google Scholar
• Arastehfar A, Carvalho A, Nguyen MH, et al. COVID-19-associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions? J Fungi (Basel). 2020;6:211.
   Google Scholar
• Hoenigl M, Seidel D, and Carvalho A, et al., The emergence of COVID-19-associated mucormycosis: analysis of cases from 18 countries. May 12 2021 Epub ahead of print doi:https://doi.org/10.1016/S2666-5247(21)00238-8 ; Lancet Microbe. [in press]
   Google Scholar
• www.gaffi.org/3rd-essential-diagnostics-list-launch. Accessed December 2021
   Google Scholar
• Guegan H, Iriart X, Bougnoux ME, et al. Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis. J Infect. 2020 Aug;81(2):311–317. DOI:https://doi.org/10.1016/j.jinf.2020.05.051.
   PubMed Web of Science ®Google Scholar
• Mercier T, Reynders M, Beuselinck K, et al. Serial detection of circulating mucorales DNA in Invasive Mucormycosis: a Retrospective Multicenter Evaluation. J Fungi (Basel). 2019 Dec 3;5(4):113. DOI:https://doi.org/10.3390/jof5040113.
   Google Scholar